Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on September 30, 2026

Sep. 30, 2026

Federal Court Rules in Favor of Genius Group, Denying All Motions to Dismiss in RICO Lawsuit

Indeterminate GlobeNewswire

Sep. 30, 2026

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Indeterminate GlobeNewswire

Sep. 30, 2026

Ocugen to Participate in Upcoming Scientific Conferences

Indeterminate GlobeNewswire

Sep. 30, 2026

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

Indeterminate GlobeNewswire

Sep. 30, 2026

Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury

Indeterminate GlobeNewswire

Sep. 30, 2026

Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Sep. 30, 2026

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation

Indeterminate GlobeNewswire

Sep. 30, 2026

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

ONAR Completes Largest Acquisition in Company History: Advertise Purple Adds $17.1 Million of Revenue and $4.4 Million of Net Income, Bringing Combined Pro Forma Revenue to Approximately $23.5 Million

Indeterminate GlobeNewswire

Sep. 30, 2026

NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression

Indeterminate GlobeNewswire

Sep. 30, 2026

Tiziana Life Sciences Files for Orphan Drug Designation with the FDA for Intranasal Foralumab for the Treatment of Multiple System Atrophy (MSA)

Indeterminate GlobeNewswire

Sep. 30, 2026

Ambow Launches HybriU Events On Demand, Bringing AI-Powered Hybrid Events to Venues in a Single Transport Case

Indeterminate GlobeNewswire

Sep. 30, 2026

ACM Research’s Operating Subsidiary ACM Research (Shanghai) Provides Backlog Data

Indeterminate GlobeNewswire

Sep. 30, 2026

Nexera Technologies: Subsidiary Fort Technology Targets the Growing Data Center Backup-Power Market Through Acquisition of Majority Stake in Logia USA

Indeterminate GlobeNewswire

Sep. 30, 2026

Sagimet Biosciences Announces Pricing of $115.0 Million Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Sep. 30, 2026

Quantexa Receives Morgan Stanley 2026 Innovation Award

Indeterminate GlobeNewswire

Sep. 30, 2026

VisionWave Expands International Demonstration Program for Autonomous Defense Systems

Indeterminate GlobeNewswire

Sep. 30, 2026

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Studio Jadu Launches, Backing Independent Artists to Craft Animated Shows, Reach Audiences, Build Fandoms and Earn Revenue

Indeterminate GlobeNewswire

Sep. 30, 2026

Eureka Ergonomic Launches Zen & Magma Series, Introducing Two New Approaches to the Modern Executive Workspace

Indeterminate GlobeNewswire